1. FRI0575 BIOMARKER ANALYSIS FROM THE RISE-SSC STUDY OF RIOCIGUAT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC). (2nd June 2020) Authors: Distler, O.; Kramer, F.; Höfler, J.; Ghadessi, M.; Sandner, P.; Allanore, Y.; Denton, C.; Kuwana, M.; Matucci-Cerinic, M.; Pope, J.; Atsumi, T.; Bečvář, R.; Czirják, L.; De Langhe, E.; Hachlla, E.; Ishii, T.; Ishikawa, O.; Johnson, S.; Laapas, K.; Riccieri, V. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0249 LONG-TERM EXTENSION RESULTS OF RISE-SSC, A RANDOMIZED TRIAL OF RIOCIGUAT IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC). (2nd June 2020) Authors: Khanna, D.; Pope, J.; Matucci-Cerinic, M.; Kuwana, M.; Denton, C.; Allanore, Y.; Wosnitza, M.; Truchetet, M. E.; Szücs, G.; Stevens, W.; Steen, V.; Stagnaro, C.; Smith, V.; Silver, R.; Schiopu, E.; Riccieri, V.; Kramer, F.; Johnson, S.; Ishikawa, O.; Ishii, T. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗